|
Malcolm Farnsworth joined Cardiva in January 2008. Previously, Mr. Farnsworth served as Executive Vice President and Chief Financial Officer at POINT Biomedical Corporation, a specialty pharmaceutical company developing pharmaceutical imaging agents to detect coronary artery disease. Prior to that, he served as Vice President of Finance and Chief Financial Officer at Gynecare, Inc., a medical device company, that was acquired by Johnson & Johnson after its IPO in 1996. Before that he served as Vice President of Finance and Chief Financial Officer at Origin Medsystems, a minimally invasive surgical device company that was acquired by Eli Lilly and merged into Guidant. He holds an M.B.A. degree from the Haas School, University of California at Berkeley and a B.S. degree in Business and Economics from Lehigh University. | 